Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs

World Journal of Gastroenterology

Volumn 19, Issue 39, 2013, Pages 6604-6612

  Morita, Hiroki ^a   Mochiki, Erito ^a   Takahashi, Nobuyuki ^b   Kawamura, Kiyoshi ^b   Watanabe, Akira ^a   Sutou, Toshinaga ^a   Ogawa, Atsushi ^a   Yanai, Mitsuhiro ^a   Ogata, Kyoichi ^a   Fujii, Takaaki ^a   Ohno, Tetsuro ^a   Tsutsumi, Souichi ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b RaQualia Pharma Inc   (Japan)

Author keywords

5 hydroxytryptamine receptor antagonist; Colonic motility; Irritable bowel syndrome

Indexed keywords

ONDANSETRON; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; ILEOCECAL VALVE; MALE; MOTOR ACTIVITY; NONHUMAN; STOMACH ANTRUM; STOMACH MUSCLE; TRANSDUCER;

5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONIST; COLONIC MOTILITY; IRRITABLE BOWEL SYNDROME;

ANIMALS; COLON; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; ILEUM; MALE; MODELS, ANIMAL; MYOELECTRIC COMPLEX, MIGRATING; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; SEROTONIN 5-HT4 RECEPTOR ANTAGONISTS; STOMACH; TIME FACTORS; TRANSDUCERS, PRESSURE;

EID: 84886899876     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i39.6604     Document Type: Article

References (45)

1. Gershon MD. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20 Suppl 7: 3-14 [PMID: 15521849]
2. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132: 397-414 [PMID: 17241888 DOI: 10.1053/j.gastro.2006.11.002]
3. Gershon MD. 5-HT (serotonin) physiology and related drugs. Curr Opin Gastroenterol 2000; 16: 113-120 [PMID: 17024028 DOI: 10.1097/00001574-200003000-00004]
4. Wade PR, Tamir H, Kirchgessner AL, Gershon MD. Analysis of the role of 5-HT in the enteric nervous system using anti-idiotopic antibodies to 5-HT receptors. Am J Physiol 1994; 266: G403-G416 [PMID: 8166280]
5. Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta 2009; 403: 47-55 [PMID: 19361459 DOI: 10.1016/ j.cca.2009.01.028]
6. Kim DY, Camilleri M. Serotonin: a mediator of the braingut connection. Am J Gastroenterol 2000; 95: 2698-2709 [PMID: 11051338]
7. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13 Suppl 2: 15-30 [PMID: 10429737 DOI: 10.1046/j.1365-2036.1999.00002.x-i2]
8. Coleman NS, Marciani L, Blackshaw E, Wright J, Parker M, Yano T, Yamazaki S, Chan PQ, Wilde K, Gowland PA, Perkins AC, Spiller RC. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther 2003; 18: 1039-1048 [PMID: 14616171 DOI: 10.1046/j.1365-2036.2003.01797.x]
9. Inui A, Yoshikawa T, Nagai R, Yoshida N, Ito T. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol 2002; 90: 313-320 [PMID: 12501007 DOI: 10.1254/jjp.90.313]
10. Jin JG, Foxx-Orenstein AE, Grider JR. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther 1999; 288: 93-97 [PMID: 9862758]
11. Nagakura Y, Ito H, Kamato T, Nishida A, Miyata K. Effect of a selective 5-HT3 receptor agonist on gastric motility in fasted and fed dogs. Eur J Pharmacol 1997; 327: 189-193 [PMID: 9200559 DOI: 10.1016/S0014-2999(97)89660-4]
12. Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA. 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. Br J Pharmacol 2000; 131: 927-932 [PMID: 11053213 DOI: 10.1038/sj.bjp.0703615]
13. Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011; 140: 761-765 [PMID: 21256129 DOI: 10.1053/ j.gastro.2011.01.032]
14. Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer. Neurogastroenterol Motil 2008; 20: 557-565 [PMID: 18221252 DOI: 10.1111/j.1365-2982.2007.01069.x]
15. Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T. Restraint stress stimulates colonic motility via central corticotropinreleasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1037-G1044 [PMID: 17158256 DOI: 10.1152/ajpgi. 00419.2006]
16. Miyata K, Ito H, Fukudo S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 1998; 274: G827-G831 [PMID: 9612262]
17. Yoshida N, Mizumoto A, Iwanaga Y, Itoh Z. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991; 256: 272-278 [PMID: 1846418]
18. Hayashi K, Shibata C, Nagao M, Sato M, Kakyo M, Kinouchi M, Saijo F, Miura K, Ogawa H, Sasaki I. Intracolonic capsaicin stimulates colonic motility and defecation in conscious dogs. Surgery 2010; 147: 789-797 [PMID: 20079916 DOI: 10.1016/j.surg.2009.11.019]
19. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994; 35: 536-541 [PMID: 8174993 DOI: 10.1136/gut.35.4.536]
20. Bush TG, Spencer NJ, Watters N, Sanders KM, Smith TK. Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro. Am J Physiol Gastrointest Liver Physiol 2001; 281: G974-G983 [PMID: 11557518]
21. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990; 35: 477-480 [PMID: 2138532 DOI: 10.1007/BF01536922]
22. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci 1989; 34: 1511-1515 [PMID: 2529108 DOI: 10.1007/BF01537102]
23. Gore S, Gilmore IT, Haigh CG, Brownless SM, Stockdale H, Morris AI. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther 1990; 4: 139-144 [PMID: 2151757 DOI: 10.1111/j.1365-2036.1990.tb00458.x]
24. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc 1992; 67: 732-738 [PMID: 1434911 DOI: 10.1016/ S0025-6196(12)60797-6]
25. Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS. 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 2002; 135: 1144-1151 [PMID: 11877320]
26. Ohashi-Doi K, Himaki D, Nagao K, Kawai M, Gale JD, Furness JB, Kurebayashi Y. A selective, high affinity 5-HT 2B receptor antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterol Motil 2010; 22: e69-e76 [PMID: 19740115 DOI: 10.1111/j.1365-2982.2009.01395.x]
27. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008; 55: 1072-1080 [PMID: 18687345 DOI: 10.1016/ j.neuropharm.2008.07.016]
28. Talley NJ. Serotoninergic neuroenteric modulators. Lancet 2001; 358: 2061-2068 [PMID: 11755632 DOI: 10.1016/ S0140-6736(01)07103-3]
29. Prins NH, Van Haselen JF, Lefebvre RA, Briejer MR, Akkermans LM, Schuurkes JA. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle. Br J Pharmacol 1999; 127: 1431-1437 [PMID: 10455293 DOI: 10.1038/sj.bjp.0702665]
30. McLean PG, Coupar IM, Molenaar P. A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol 1995; 115: 47-56 [PMID: 7647983 DOI: 10.1111/j.1476-5381.1995.tb16318.x]
31. Tam FS, Hillier K, Bunce KT, Grossman C. Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle. Br J Pharmacol 1995; 115: 172-176 [PMID: 7647972 DOI: 10.1111/j.1476-5381.1995.tb16335.x]
32. Itoh Z, Honda R, Takeuchi S, Aizawa I, Takayanagi R. An extraluminal force transducer for recording contractile activity of the gastrointestinal smooth muscle in the conscious dogs: its construction and implantation. Gastroenterol Jpn 1977; 12: 275-283 [PMID: 590700]
33. Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 1994; 111: 332-338 [PMID: 8012715]
34. Takahashi N, Inagaki K, Taniguchi K, Sakaguchi Y, Kawamura K. The novel 5-HT2B receptor antagonist, RQ-00310941, attenuates visceral hypersensitivity and abnormal defecation in rat models. Gastroenterology 2011; 140: S-607 [DOI: 10.1016/S0016-5085(11)62513-4]
35. Itoh Z, Takeuchi S, Aizawa I, Takayanagi R. Characteristic motor activity of the gastrointestinal tract in fasted conscious dogs measured by implanted force transducers. Am J Dig Dis 1978; 23: 229-238 [PMID: 665611 DOI: 10.1007/ BF01072323]
36. Nagakura Y, Kamato T, Nishida A, Ito H, Yamano M, Miyata K. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Naunyn Schmiedebergs Arch Pharmacol 1996; 353: 489-498 [PMID: 8740141 DOI: 10.1007/BF00169167]
37. Ataka K, Kuge T, Fujino K, Takahashi T, Fujimiya M. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Auton Neurosci 2007; 133: 136-145 [PMID: 17182287 DOI: 10.1016/j.autneu.2006.11.002]
38. Morita H, Mochiki E, Ogawa A, Yanai M, Toyomasu Y, Tabe Y, Ohno T, Tsutsumi S, Asao T, Kuwano H. Effects of denervation at ileocecal junction and ileocecal resection in dogs. Neurogastroenterol Motil 2012; 24: 86-93, e14 [PMID: 22082338 DOI: 10.1111/j.1365-2982.2011.01810.x]
39. Heredia DJ, Dickson EJ, Bayguinov PO, Hennig GW, Smith TK. Localized release of serotonin (5-hydroxytryptamine) by a fecal pellet regulates migrating motor complexes in murine colon. Gastroenterology 2009; 136: 1328-1338 [PMID: 19138686 DOI: 10.1053/j.gastro.2008.12.010]
40. Dickson EJ, Heredia DJ, Smith TK. Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex. Am J Physiol Gastrointest Liver Physiol 2010; 299: G144-G157 [PMID: 20413719 DOI: 10.1152/ajpgi.00496.2009]
41. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut 2000; 47: 667-674 [PMID: 11034583 DOI: 10.1136/gut.47.5.667]
42. Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010; 25: 1232-1238 [PMID: 20594249 DOI: 10.1111/j.1440-1746.2010.06338.x]
43. Bassil AK, Taylor CM, Bolton VJ, Gray KM, Brown JD, Cutler L, Summerfield SG, Bruton G, Winchester WJ, Lee K, Sanger GJ. Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology. Br J Pharmacol 2009; 158: 252-258 [PMID: 19371340 DOI: 10.1111/ j.1476-5381.2009.00155.x]
44. Briejer MR, Prins NH, Schuurkes JA. Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs. Neurogastroenterol Motil 2001; 13: 465-472 [PMID: 11696108 DOI: 10.1046/j.1365-2982.2001.00280.x]
45. Hata F, Kataoka T, Takeuchi T, Yagasaki O, Yamano N. Differences in control of descending inhibition in the proximal and distal regions of rat colon. Br J Pharmacol 1990; 101: 1011-1015 [PMID: 2085703 DOI: 10.1111/j.1476-5381.1990. tb14198.x]